Equities

Jiangsu Recbio Technology Co Ltd

Jiangsu Recbio Technology Co Ltd

Actions
  • Price (HKD)8.46
  • Today's Change-0.44 / -4.94%
  • Shares traded2.00k
  • 1 Year change-29.38%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments9121,3251,183
Total Receivables, Net391352
Total Inventory1186639
Prepaid expenses516.535.39
Other current assets, total9.229.5316
Total current assets1,1291,4201,295
Property, plant & equipment, net1,003814511
Goodwill, net9.319.319.31
Intangibles, net413422
Long term investments2.403180
Note receivable - long term------
Other long term assets------
Total assets2,1862,3101,919
LIABILITIES
Accounts payable1156317
Accrued expenses208184105
Notes payable/short-term debt000
Current portion long-term debt/capital leases61227.86
Other current liabilities, total60619.72
Total current liabilities444329139
Total long term debt59026169
Total debt65128377
Deferred income tax5.535.535.53
Minority interest(0.49)(8.8)(0.01)
Other liabilities, total766132
Total liabilities1,115648246
SHAREHOLDERS EQUITY
Common stock483483448
Additional paid-in capital2,5832,5831,954
Retained earnings (accumulated deficit)(1941)(1404)(729)
Treasury stock - common(54)----
Unrealized gain (loss)------
Other equity, total------
Total equity1,0711,6621,673
Total liabilities & shareholders' equity2,1862,3101,919
Total common shares outstanding479483479
Treasury shares - common primary issue--00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.